Shilpa Medicare Limited
ICICI Prudential Mutual Fund decreased its stake in Shilpa Medicare from 1.90% to 1.17%, selling 14,34,531 shares. The value of the sold shares was ₹89.09 Cr at ₹620.25 apiece.
A pharmaceutical manufacturer producing niche active pharmaceutical ingredients, intermediates, and formulations for domestic and international markets. The company operates through injectable and oral dosage forms, offering contract research and manufacturing services to clients. Established in 1987, it maintains a vertically integrated manufacturing base across multiple therapeutic areas and serves both branded and generic segments through its subsidiary operations.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.